Filing Details
- Accession Number:
- 0001225208-13-010911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-05-01 17:58:32
- Reporting Period:
- 2013-04-29
- Filing Date:
- 2013-05-01
- Accepted Time:
- 2013-05-01 17:58:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 14272 | Bristol Myers Squibb Co | BMY | Pharmaceutical Preparations (2834) | 220790350 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1202294 | Elliot Sigal | Bristol-Myers Squibb Company 345 Park Avenue New York NY 10154 | Evp, Cso & President R&D | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Acquisiton | 2013-04-29 | 36,503 | $24.74 | 221,524 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-04-29 | 25,795 | $22.73 | 247,319 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-04-29 | 11,092 | $24.74 | 258,411 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 9,600 | $40.00 | 248,811 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 21,856 | $39.90 | 226,955 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 31,594 | $39.90 | 195,361 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 41,868 | $39.92 | 153,493 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-04-30 | 202,405 | $24.74 | 355,898 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Acquisiton | 2013-04-30 | 103,500 | $25.45 | 459,398 | No | 4 | M | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 88,132 | $39.63 | 371,266 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 90,234 | $39.61 | 281,032 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 175,143 | $39.61 | 105,889 | No | 4 | S | Direct | |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 18,313 | $39.97 | 19,099 | No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 919 | $39.65 | 18,180 | No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 18,313 | $39.97 | 19,099 | No | 4 | S | Indirect | By Ruth L. Sigal Irrevocable Trust |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 919 | $39.65 | 18,180 | No | 4 | S | Indirect | By Ruth L. Sigal Irrevocable Trust |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-29 | 9,157 | $39.97 | 9,550 | No | 4 | S | Indirect | By Sigal Family Investments, LLC |
| Common Stock, $0.10 Par Value | Disposition | 2013-04-30 | 459 | $39.65 | 9,091 | No | 4 | S | Indirect | By Sigal Family Investments, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
| No | 4 | S | Indirect | By C. Elliott Sigal 2012 Irrevocable Trust |
| No | 4 | S | Indirect | By Ruth L. Sigal Irrevocable Trust |
| No | 4 | S | Indirect | By Ruth L. Sigal Irrevocable Trust |
| No | 4 | S | Indirect | By Sigal Family Investments, LLC |
| No | 4 | S | Indirect | By Sigal Family Investments, LLC |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-04-29 | 25,795 | $0.00 | 25,795 | $22.73 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-04-29 | 11,092 | $0.00 | 11,092 | $24.74 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-04-29 | 36,503 | $0.00 | 36,503 | $24.74 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-04-30 | 103,500 | $0.00 | 103,500 | $25.45 |
| Common Stock, $0.10 Par Value | Executive Option (right to buy) | Disposition | 2013-04-30 | 202,405 | $0.00 | 202,405 | $24.74 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2016-03-06 | No | 4 | M | Direct | |
| 288,908 | 2016-11-30 | No | 4 | M | Direct | |
| 252,405 | 2016-11-30 | No | 4 | M | Direct | |
| 0 | 2015-02-28 | No | 4 | M | Direct | |
| 50,000 | 2016-11-30 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, $0.10 Par Value | 1,628 | Indirect | By BMY Savings & Investment Program |
Footnotes
- Includes shares sold to cover exercise price and taxes in accordance with broker's procedures for sell-to-cover transactions.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.62 to $39.65, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.60 to $39.67, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $39.90 to $40.00, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of the reported shares for purposes of Section 16 or for any other purpose.
- Based on a plan statement as of the end of the most recent fiscal quarter.
- Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 7, 2006.
- One-third of the stock option award vested on each of the third, fourth and fifth anniversaries of the grant date, which was December 1, 2006.
- Twenty-five percent of the stock option award vested on each of the first, second, third and fourth anniversaries of the grant date, which was March 1, 2005.
Billionaire Hedge Funds
